Jones William Benton Insider Trades

Insider Trading History

Track insider trading activity for Jones William Benton. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $4.69M 400,000 shares
Last Trade
Dec 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.52M 400,000 shares
$8.81
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $0 0 shares
Last Trade
Jun 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$67.7k 19,357 shares
$3.50
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $2.03M 173,130 shares
Last Trade
Jun 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$67.7k 19,357 shares
$3.50
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $3.52M 300,000 shares
Last Trade
Dec 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.5M 300,000 shares
$4.99
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $1.8M 153,773 shares
Last Trade
May 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$75.2k 39,357 shares
$1.91
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $2.34M 200,000 shares
Last Trade
Dec 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$328k 200,000 shares
$1.64
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $1.57M 133,773 shares
Last Trade
Dec 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15.8k 20,000 shares
$0.79
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $1.88M 160,000 shares
Last Trade
Aug 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$154k 160,000 shares
$0.96
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $1.88M 160,000 shares
Last Trade
Sep 09, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$416k 160,000 shares
$2.60
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $1.88M 160,000 shares
Last Trade
Dec 16, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$642k 160,000 shares
$4.01
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $1.88M 160,000 shares
Last Trade
Dec 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$566k 160,000 shares
$3.54
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $1.17M 100,000 shares
Last Trade
Dec 12, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$594k 100,000 shares
$5.94
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
See Remarks
Holding Value $469k 40,000 shares
Last Trade
Dec 13, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$424k 40,000 shares
$10.60
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
VP Pharmaceutical Development
Holding Value $293k 25,000 shares
Last Trade
Dec 07, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$409k 25,000 shares
$16.37
$11.72
Corvus Pharmaceuticals
Corvus Pharmaceuticals CRVS
VP Pharmaceutical Development
Holding Value $703k 60,000 shares
Last Trade
Mar 22, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$11.72

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up